Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma: reply

Rheumatology (Oxford). 2021 Feb 1;60(2):e79-e80. doi: 10.1093/rheumatology/keaa799.

Authors

Marco Caminati¹, Matteo Maule², Francesca Nalin², Gianenrico Senna¹, Claudio Lunardi¹

Affiliations

¹ Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy.
² School of Specialization in Allergy and Clinical Immunology, Department of Medicine, University of Verona, Verona, Italy.

PMID: 33280054
DOI: 10.1093/rheumatology/keaa799

No abstract available

Publication types

Comment

MeSH terms

Asthma* / drug therapy
Churg-Strauss Syndrome* / chemically induced
Churg-Strauss Syndrome* / drug therapy
Eosinophils
Granulomatosis with Polyangiitis*
Humans
Interleukin-5

Substances

Interleukin-5